ERBB2 and neoplasm: So far, well known biomarkers such as including ER and HER2, as well as others, including pSTAT3 expression, LDH, and tumor-infiltrating lymphocytes, etc. – have been studied to elucidate breast cancer biology and survival outcome (2–4), further endeavor is still required to understand tumor nature.